[go: up one dir, main page]

Martišová, 2007 - Google Patents

Implication of the Gabaergic System in Altered Responses to Stress Associated to Maternal Separation

Martišová, 2007

View PDF
Document ID
12755237163556959862
Author
Martišová E
Publication year

External Links

Snippet

in English language-diploma thesis Implication of the Gabaergic System in Altered Responses to Stress Associated to Maternal Separation Eva Martišová This diploma thesis studied whether the GABA system alters responses to stress induced by maternal separation …
Continue reading at dspace.cuni.cz (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Brambilla et al. GABAergic dysfunction in mood disorders
Lanfumey et al. Corticosteroid–serotonin interactions in the neurobiological mechanisms of stress-related disorders
McEwen et al. Adrenal steroid receptors and actions in the nervous system
Ring The central vasopressinergic system: examining the opportunities for psychiatric drug development
Melcangi et al. Neuroactive steroids: state of the art and new perspectives
Ciranna et al. 5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders
Agis-Balboa et al. 5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients
Mitsukawa et al. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders
Pinna et al. Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice
Pytka et al. The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect
Hill et al. Sex-dependent and region-specific changes in TrkB signaling in BDNF heterozygous mice
Numakawa et al. Functional interactions between steroid hormones and neurotrophin BDNF
Shishkina et al. Stress-induced activation of the brainstem Bcl-xL gene expression in rats treated with fluoxetine: correlations with serotonin metabolism and depressive-like behavior
Bazyan et al. Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures
Trousse et al. Knockdown of the CXCL12/CXCR7 chemokine pathway results in learning deficits and neural progenitor maturation impairment in mice
Yamauchi et al. Neurotensin type 2 receptor is involved in fear memory in mice
Hossain et al. MDGA1-deficiency attenuates prepulse inhibition with alterations of dopamine and serotonin metabolism: An ex vivo HPLC-ECD analysis
Multani et al. Biomarkers for drugs of abuse and neuropsychiatric disorders: models and mechanisms
Martišová Implication of the Gabaergic System in Altered Responses to Stress Associated to Maternal Separation
Ritsner et al. Dehydroepiandrosterone and pregnenolone alterations in schizophrenia
Purdy et al. Neuroactive steroids and ethanol
US20110296540A1 (en) Assay for screening antidepressants
Wegener et al. Nitric Oxide in Major Depressive Disorder
Comasco et al. Constitutive serotonin transporter reduction resembles maternal separation with regard to stress-related gene expression
Gaetano Stress in critical period of early life influences glutamate excitatory neurotransmission: implication for neuropsychiatric disorders